NovoCure (NVCR) Interest Coverage Ratio Growth (3y) (2017 - 2022)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -7.80% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -1.00% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 12.94% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -35.05% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.28% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -4.98% |
| 10 | NovoCure | 1.90 Bn | 1.47 Bn | 135.13 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -127.82% |
| Mar 31, 2022 | 43.25% |
| Dec 31, 2021 | -38.94% |
| Sep 30, 2021 | -25.41% |
| Jun 30, 2021 | -74.13% |
| Mar 31, 2021 | 76.65% |
| Dec 31, 2020 | 58.19% |
| Sep 30, 2020 | 49.98% |
| Jun 30, 2020 | 33.10% |
| Mar 31, 2020 | 36.65% |
| Dec 31, 2019 | 26.41% |
| Sep 30, 2019 | 28.40% |
| Jun 30, 2019 | 26.29% |
| Mar 31, 2019 | 64.60% |
| Dec 31, 2018 | 51.44% |
| Sep 30, 2018 | 58.20% |
| Jun 30, 2018 | 56.95% |
| Mar 31, 2018 | 58.72% |
| Dec 31, 2017 | 74.75% |
| Sep 30, 2017 | 79.90% |